TPI, PGAM1, MNSOD were selected for this study based upon the studies of Zamani-Ahmadmahmudi et al. 39, who by serological proteome analysis (SERPA) identified these as potential autoantigens with significantly higher immunoreactivity in canine mammary cancer sera samples. The gene discussed is SOD2; the disease is breast cancer.